PDF herunterladen
Endosc Int Open 2015; 03(05): E409-E417
DOI: 10.1055/s-0034-1392552
Review
© Georg Thieme Verlag KG Stuttgart · New York

Low risk of bacteremia after endoscopic variceal therapy for esophageal varices: a systematic review and meta-analysis

Yi Jia
1   Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
,
Alok Dwivedi
2   Division of Biostatistics & Epidemiology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
,
Sherif Elhanafi
1   Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
,
Arleen Ortiz
1   Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
,
Mohamed Othman
1   Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
,
Marc Zuckerman
1   Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 29. Dezember 2014

accepted after revision 07. Mai 2015

Publikationsdatum:
11. August 2015 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Background and study aims: Endoscopic variceal ligation (EVL) and endoscopic variceal sclerotherapy (EVS) are the main therapeutic procedures for the emergency treatment and secondary prophylaxis of esophageal varices in cirrhotics. Post-endoscopic bacteremia has been reported after EVS and EVL, but data on the frequency of bacteremia are conflicting. This study aims to provide incidences of bacteremia after EVS and EVL in different settings through meta-analysis.

Methods: Only prospective or randomized studies were included in this meta-analysis. Binomial distribution was used to compute variance for each study. Random effects models were used as the final model for estimating the effect size and 95 % confidence interval. Adjusted effects were obtained using meta-regression analysis.

Results: Nineteen prospective studies involving 1001 procedures in 587 patients were included in the meta-analysis on the risk of bacteremia after EVS or EVL in cirrhotics with esophageal varices. The frequency of bacteremia after endoscopic variceal therapy was 13 %. The frequency of bacteremia after EVS (17 %) was higher than after EVL (6 %) with no statistically significant difference (P = 0.106). The frequency of bacteremia after elective EVS (14 %) was significantly less than after emergency EVS (22 %) (P < 0.001). The frequency of bacteremia after elective EVL (7.6 %) was not significantly different from after emergency EVL (3.2 %) (P = 0.850).

Conclusions: The incidence of bacteremia is low in patients with cirrhosis and varices after esophageal variceal therapy. These results are consistent with our current guidelines that antibiotic prophylaxis before endoscopic variceal therapy is only necessary for bleeding patients.

Supplemental Tables 3, 4

 

  • References

  • 1 Riggio O, Angeloni S, Nicolini G et al. Endoscopic screening for esophageal varices in cirrhotic patients. Hepatology 2002; 35: 501-502
    CrossrefPubMedGoogle Scholar
  • 2 Banerjee S, Shen B, Baron TH et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2008; 67: 791-798
    CrossrefPubMedGoogle Scholar
  • 3 Zuckerman MJ, Menzies IS, Ho H et al. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004; 49: 621-626
    CrossrefPubMedGoogle Scholar
  • 4 Lin OS, Wu SS, Chen YY et al. Bacterial peritonitis after elective endoscopic variceal ligation: a prospective study. Am J Gastroenterol 2000; 95: 214-217
    CrossrefPubMedGoogle Scholar
  • 5 Nelson DB. Infection control during gastrointestinal endoscopy. Can J Gastroenterol 2007; 21: 13-15
    PubMedGoogle Scholar
  • 6 Brann OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001; 3: 285-292
    CrossrefPubMedGoogle Scholar
  • 7 Lo GH, Lai KH, Shen MT et al. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 1994; 40: 675-679
    PubMedGoogle Scholar
  • 8 Tseng CC, Green RM, Burke SK et al. Bacteremia after endoscopic band ligation of esophageal varices. Gastrointest Endosc 1992; 38: 336-337
    CrossrefPubMedGoogle Scholar
  • 9 Sauerbruch T, Holl J, Ruckdeschel G et al. Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy 1985; 17: 170-172
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 10 Camara DS, Gruber M, Barde CJ et al. Transient bacteremia following endoscopic injection sclerotherapy of esophageal varices. Arch Intern Med 1983; 143: 1350-1352
    CrossrefPubMedGoogle Scholar
  • 11 Ho H, Zuckerman MJ, Wassem C. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. Gastroenterology 1991; 101: 1642-1648
    CrossrefPubMedGoogle Scholar
  • 12 Qureshi W, Adler DG, Davila R et al. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 2005; 62: 651-655
    CrossrefPubMedGoogle Scholar
  • 13 Garcia-Tsao G, Sanyal AJ, Grace ND et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007; 102: 2086-2102
    CrossrefPubMedGoogle Scholar
  • 14 Hwang JH, Shergill AK, Acosta RD et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc 2014; 80: 221-227
    CrossrefPubMedGoogle Scholar
  • 15 Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269
    CrossrefPubMedGoogle Scholar
  • 16 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605
    CrossrefPubMedGoogle Scholar
  • 17 Berner JS, Gaing AA, Sharma R et al. Sequelae after esophageal variceal ligation and sclerotherapy: a prospective randomized study. Am J Gastroenterol 1994; 89: 852-858
    PubMedGoogle Scholar
  • 18 Kulkarni SG, Parikh SS, Dhawan PS et al. High frequency of bacteremia with endoscopic treatment of esophageal varices in advanced cirrhosis. Indian J Gastroenterol 1999; 18: 143-145
    PubMedGoogle Scholar
  • 19 Bonilha DQ, Correia LM, Monaghan M et al. Prospective study of bacteremia rate after elective band ligation and sclerotherapy with cyanoacrylate for esophageal varices in patients with advanced liver disease. Arq Gastroenterol 2011; 48: 248-251
    PubMedGoogle Scholar
  • 20 Cohen LB, Korsten MA, Scherl EJ et al. Bacteremia after endoscopic injection sclerosis. Gastrointest Endosc 1983; 29: 198-200
    CrossrefPubMedGoogle Scholar
  • 21 Brayko CM, Kozarek RA, Sanowski RA et al. Bacteremia during esophageal variceal sclerotherapy: its cause and prevention. Gastrointest Endosc 1985; 31: 10-12
    CrossrefPubMedGoogle Scholar
  • 22 Snady H, Korsten MA, Waye JD. The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy. Gastrointest Endosc 1985; 31: 243-246
    CrossrefPubMedGoogle Scholar
  • 23 Low DE, Shoenut JP, Kennedy JK et al. Infectious complications of endoscopic injection sclerotherapy. Arch Intern Med 1986; 146: 569-571
    CrossrefPubMedGoogle Scholar
  • 24 Hegnhoj J, Andersen JR, Jarlov JO et al. Bacteriaemia after injection sclerotherapy of oesophageal varices. Liver 1988; 8: 167-171
    PubMedGoogle Scholar
  • 25 Lorgat F, Madden MV, Kew G et al. Bacteremia after injection of esophageal varices. Surg Endosc 1990; 4: 18-19
    CrossrefPubMedGoogle Scholar
  • 26 Rolando N, Gimson A, Philpott-Howard J et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 1993; 18: 290-294
    CrossrefPubMedGoogle Scholar
  • 27 Selby WS, Norton ID, Pokorny CS et al. Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 1994; 40: 680-684
    PubMedGoogle Scholar
  • 28 da Silveira RohrMR, Siqueira ES, Brant CQ et al. Prospective study of bacteremia rate after elastic band ligation and sclerotherapy of esophageal varices in patients with hepatosplenic schistosomiasis. Gastrointest Endosc 1997; 46: 321-323
    CrossrefPubMedGoogle Scholar
  • 29 Maulaz EB, de Mattos AA, Pereira-Lima J et al. Bacteremia in cirrhotic patients submitted to endoscopic band ligation of esophageal varices. Arq Gastroenterol 2003; 40: 166-172
    CrossrefPubMedGoogle Scholar
  • 30 Rey JR, Axon A, Budzynska A et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. European Society of Gastrointestinal Endoscopy. Endoscopy 1998; 30: 318-324
    PubMedGoogle Scholar
  • 31 Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280-287
    CrossrefPubMedGoogle Scholar
  • 32 Woods KL, Qureshi WA. Long-term endoscopic management of variceal bleeding. Gastrointest Endosc Clin N Am 1999; 9: 253-270
    PubMedGoogle Scholar
  • 33 Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. NEJM 1992; 326: 1527-1532
    CrossrefPubMedGoogle Scholar
  • 34 Laine L, el-Newihi HM, Migikovsky B et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993; 119: 1-7
    CrossrefPubMedGoogle Scholar
  • 35 Baroncini D, Milandri GL, Borioni D et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997; 29: 235-240
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 36 Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol 2002; 17: 1064-1069
    CrossrefPubMedGoogle Scholar
  • 37 Wahl P, Lammer F, Conen D et al. Septic complications after injection of N-butyl-2-cyanoacrylate: report of two cases and review. Gastrointest Endosc 2004; 59: 911-916
    CrossrefPubMedGoogle Scholar
  • 38 Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23: 73-98
    CrossrefPubMedGoogle Scholar
  • 39 Chang YJ, Park JJ, Joo MK et al. Long-term outcomes of prophylactic endoscopic histoacryl injection for gastric varices with a high risk of bleeding. Dig Dis Sci 2010; 55: 2391-2397
    CrossrefPubMedGoogle Scholar
  • 40 Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 1999; 473: 11-30
    PubMedGoogle Scholar
  • 41 Garcia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis?. J Hepatol 2001; 34: 150-155
    PubMedGoogle Scholar
  • 42 Lee S, Son SC, Han MJ et al. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol 2008; 14: 3884-3890
    CrossrefPubMedGoogle Scholar
  • 43 Fukui H. How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage?. J Gastroenterol Hepatol 2011; 26: 423-425
    CrossrefPubMedGoogle Scholar